D-0694-2026 Class II Ongoing

Recalled by Blaine Labs Inc — Santa Fe Springs, CA

FDA drug recall D-0694-2026 was initiated by Blaine Labs Inc on Apr 8, 2026 and is designated Class II. Reason for recall: CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry The recall status is ongoing. Affected quantity: 144 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 8, 2026
Initiation Date
Apr 8, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
144 bottles

Product description

TRIPENICOL S Antifungal Solution (Undecylenic Acid 25%), 1.25 FL OZ (37.5 mL) bottle, Manufactured For: Trifluent Pharma, LLC, San Antonio, TX 78213, NDC 73352-550-01.

Reason for recall

CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

Distribution pattern

Nationwide in the USA

Code information

Lot #BL3411R, Exp 6/8/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0694-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0694-2026. Report a data issue: hello@regdatalab.com.